Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE

Last updated on 2019-09-18 History
Report ID 7392
Drug Identification Number 02408090
Brand name MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name BUPRENORPHINE/NALOXONE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPRENORPHINE NALOXONE
Strength(s) 2MG 0.5MG
Dosage form(s) TABLET
Route of administration SUBLINGUAL
Packaging size 100BT
ATC code N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-06-26
Estimated end date Unknown
Actual end date 2019-09-17
Shortage status Resolved
Updated date 2019-09-18
Company comments discontinued in ID 94044. Last lot 3085355 exp 2019-05-31
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v143 2019-09-18 English Compare
v142 2019-09-17 French Compare
v141 2019-09-17 English Compare
v140 2018-06-29 French Compare
v139 2018-06-29 English Compare
v138 2018-06-25 French Compare
v137 2018-06-25 English Compare
v136 2018-06-09 English Compare
v135 2018-05-25 French Compare
v134 2018-05-25 English Compare
v133 2018-05-18 French Compare
v132 2018-05-18 English Compare
v131 2018-04-30 French Compare
v130 2018-04-30 English Compare
v129 2018-04-13 French Compare
v128 2018-04-13 English Compare
v127 2018-04-13 English Compare
v126 2018-03-26 French Compare
v125 2018-03-26 English Compare
v124 2018-03-25 English Compare

Showing 1 to 20 of 143